Veterinary Vaccine Newcastle Disease, Infectious Bronchitis, Egg Drop Syndrome and Avian Influenza (H9 Subtype) Killed Vaccine for Animal Use

• Varieties: Vaccine
• Component: Virus
• Type: The First Class
• Shipping Cost: Estimated freight per unit.: about shipping cost and estimated delivery time.
• Currency: US$
• Return&refunds: You can apply for a refund up to 30 days after receipt of the products.
• Model NO.: SINVAC ND + IB + EDS +H9
• Pharmacodynamic Influential Factors: Temperature
• Storage Method: Prevent High or LowTemperature
• Veterinary Reg. No.: 010372208
• New H.S.Code: 30024200
• Shelf Life: 18 Months
• Temperature: 2-8
• Physical Property: Milky White Homogeneous Emulsion
• Usage: Injected Intramuscularly or Subcutaneously
• Transport Package: Air Way/Sea Way
• Specification: 250ml/bottle, 500ml/bottle
• Trademark: SINDER
• Origin: Beijing, China
• HS Code: 3002300000
• Production Capacity: 100000L/Year
• Package Size: 46.50cm * 45.20cm * 25.20cm
• Package Gross Weight: 13.500kg

Product Description

SINVAC ND + IB + EDS + H9
Newcastle Disease, Infectious Bronchitis, Egg Drop Syndrome and Avian Influenza (H9 Subtype) Vaccine, Inactivated (Strain La Sota + Strain M41 + Strain HSH23 + Strain WD)

(Generic name) Newcastle Disease, Infectious Bronchitis, Egg Drop Syndrome and Avian Influenza (H9 Subtype) Vaccine, Inactivated (Strain La Sota + Strain M41 + Strain HSH23 + Strain WD)
(Trade name) SINVAC ND + IB + EDS +H9
(Main Components and content) Content per dose (0.5ml): Inactivated Newcastle Disease Virus La Sota Strain ≥10^8.5EID₅₀/dose, Infectious Bronchitis Virus M41 Strain ≥10^6.5EID₅₀/dose, Egg Drop Syndrome Virus HSH23 Strain ≥1000HA, Avian Influenza (H9 Subtype, WD strain) Virus≥10^7.5EID₅₀/dose.
(Physical Property) The product is milky white homogeneous emulsion. 
(Indication and Effect) It is used for prevention of Avian Newcastle Disease, Infectious Bronchitis, Egg Drop Syndrome and H9 Avian Influenza. Immunity is generated 14-21 days post immunization. Immunization period is 6 months.
(Usage and Dosage) To be injected intramuscularly or subcutaneously at the neck area. Laying hens before laying (16-20 weeks old), 0.5ml each.
(Precaution) 
1.It can be only vaccinated for healthy chickens.
2.Inoculating this vaccine after primary immunization of Newcastle disease vaccine and avian infectious bronchitis vaccine can improve the immune prevention effect of Newcastle disease and avian infectious bronchitis.
3.The vaccine should be thoroughly shaken before use and should recover to room temperature.
4. The vaccine should be used out within 24 hours once the bottle is opened.
(Specification) 500ml/bottle 
(Package) 20bottles/carton 
(Storage) Store at 2-8ºC and the shelf life is 18 months.
(Registered Number of Approval) Veterinary Drug 010372208 
(Manufacturer) Beijing Sinder-vet Technology Co., Ltd. 

Use it under veterinarian's guidance only
Made in China
Manufacture by: Beijing Sinder-vet Technology Co., Ltd.
A subsdiary of SHANDONG SINDER TECHNOLOGY CO., LTD. 
Address: No.118, Shunyu Road, Beijing Tianzhu Airport Economic Development Zone, Shunyi District, Beijing, China. Postcode: 101302    
    

Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.

Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!

Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.

Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.